KRSNAA Stock Overview
Provides diagnostic services in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Krsnaa Diagnostics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹880.20 |
| 52 Week High | ₹1,044.00 |
| 52 Week Low | ₹528.05 |
| Beta | -0.18 |
| 1 Month Change | -9.47% |
| 3 Month Change | 3.21% |
| 1 Year Change | 21.04% |
| 3 Year Change | 33.44% |
| 5 Year Change | n/a |
| Change since IPO | -10.82% |
Recent News & Updates
Recent updates
After Leaping 30% Krsnaa Diagnostics Limited (NSE:KRSNAA) Shares Are Not Flying Under The Radar
Nov 26
Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Sep 06Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50
Aug 23Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 10Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Aug 09Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors
Jul 05Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return
Jun 16We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings
May 26Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?
Mar 14Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 16Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 31Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 17Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)
Jun 03Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 17Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)
Feb 16Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think
Nov 17Shareholder Returns
| KRSNAA | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -6.6% | -1.3% | -4.3% |
| 1Y | 21.0% | 41.8% | 19.1% |
Return vs Industry: KRSNAA underperformed the Indian Healthcare industry which returned 41.8% over the past year.
Return vs Market: KRSNAA exceeded the Indian Market which returned 19.1% over the past year.
Price Volatility
| KRSNAA volatility | |
|---|---|
| KRSNAA Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: KRSNAA has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: KRSNAA's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 3,700 | Mitesh Dave | krsnaadiagnostics.com |
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers various diagnostic services, including radiology, pathology, and teleradiology services. The company also provides health packages, such as diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, infection screening, fever profiles, etc. It serves its services to public and private hospitals, medical colleges, and community health centers.
Krsnaa Diagnostics Limited Fundamentals Summary
| KRSNAA fundamental statistics | |
|---|---|
| Market cap | ₹28.42b |
| Earnings (TTM) | ₹692.15m |
| Revenue (TTM) | ₹6.81b |
41.1x
P/E Ratio4.2x
P/S RatioIs KRSNAA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KRSNAA income statement (TTM) | |
|---|---|
| Revenue | ₹6.81b |
| Cost of Revenue | ₹1.75b |
| Gross Profit | ₹5.06b |
| Other Expenses | ₹4.37b |
| Earnings | ₹692.15m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | 21.44 |
| Gross Margin | 74.24% |
| Net Profit Margin | 10.16% |
| Debt/Equity Ratio | 20.1% |
How did KRSNAA perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield14%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 21:34 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Krsnaa Diagnostics Limited is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bharat Celly | Equirus Securities Private Limited |
| Cyndrella Carvalho | JM Financial Institutional Securities Limited |
| Jainil Shah | JM Financial Institutional Securities Limited |